0000000000397282

AUTHOR

Francisco Gonzalez-lima

showing 1 related works from this author

The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1.

2021

medicine.medical_specialtyDrug Industrybusiness.industryGeneral NeuroscienceMEDLINEGeneral MedicineDiseaseAntibodies Monoclonal HumanizedRaising (linguistics)United StatesPsychiatry and Mental healthClinical PsychologyAlzheimer DiseaseMedicineHumansAducanumabGeriatrics and GerontologybusinessIntensive care medicineDrug ApprovalJournal of Alzheimer's disease : JAD
researchProduct